Clinical Trial Update: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) [NA]

View source ↗

Summary

Multinational Phase III randomized trial CALYPSO comparing pegylated liposomal doxorubicin (CAELYX) with carboplatin vs paclitaxel with carboplatin in epithelia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Carboplatin (Paraplatin) (carboplatin)
• Paclitaxel (Taxol) (paclitaxel)
• Pegylated liposomal doxorubicin (CAELYX) (doxorubicin liposome (pegylated))

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Epithelial Ovarian Cancer | NA | Status: COMPLETED